Faculty
Oncology Division
Alphabetical list (active faculty):   
Todd A. Fehniger

Todd A. Fehniger, MD, PhD

Professor

Department of Medicine

Oncology Division

Stem Cell Biology

Bone Marrow Transplantation & Leukemia

Clinical Interests

  • Lymphoma
  • Leukemia
  • Immunotherapy
  • Hematopoietic cell transplantation

Research Interests

  • Innate immunity
  • Natural killer cell biology
  • Micro RNAs
  • Cytokines
  • Natural killer cell based therapeutics

Contact

  • 314-747-1385 (office)
  • 314-747-1547 (lab)
  • 314-362-9333 (fax)
  • Division of Oncology
    Campus Box 8007
    Washington University
    660 South Euclid Avenue
    St. Louis, MO 63110
  • Room 638 Southwest Tower (office)
  • Room 634 Southwest Tower (lab)

Biosketch

Education
1994 BS in Biological Sciences with High Distinction, State University of New York (SUNY), Buffalo, NY
2000 PhD in Molecular Virology, Immunology, and Medical Genetics, The Ohio State University, College of Medicine and Public Health, Columbus, OH
2002 MD, The Ohio State University, College of Medicine and Public Health, Columbus, OH
Post-graduate Training
2002-2004 Intern and Resident, Internal Medicine, Physician Scientist Training Pathway, Barnes-Jewish Hospital, Washington University School of Medicine, St. Louis, MO
2004-2008 Fellow, Hematology and Oncology, Washington University School of Medicine, St. Louis, MO
Academic Positions & Employment
2008-2014 Assistant Professor, Department of Medicine, Washington University School of Medicine, St. Louis, MO
2015-2020 Associate Professor, Department of Medicine, Washington University School of Medicine, St. Louis, MO
2020-present Professor, Department of Medicine, Washington University School of Medicine, St. Louis, MO
University & Hospital Appointments & Committees
2008-present Member, Siteman Cancer Center, Hematopoietic Development and Malignancy Program; Lymphoma Program Co-Leader
2008-present Member, Division of Biology and Biomedical Sciences, Immunology Program, Washington University
2008-present Member, Institute for Clinical and Translational Sciences (ICTS), Washington University
2009-2011 Data Safety Monitoring Committee for investigator initiated clinical trial 07-0916: “Phase I trial of intravenous Decitabine in combination with Arsenic trioxide and Ascorbic acid in patients with myelodysplastic syndromes”
2009-2013 Reviewer, Translational Oncology Group Seed Funding, Division of Oncology
2009 Reviewer, BJHF/ICTS Clinical and Translational Research Funding Program
2010-2013 Siteman Cancer Center Shared Resource Review Committee
2014-2018 Leukemia SPORE DRP Review Committee
2014-2017 Reviewer, BJHF/ICTS Clinical and Translational Research Funding Program
2014-2019 Member, Siteman Cancer Center Investment Program Study Section
2014-present Member, WUSM Center for Human Immunology and Immunotherapy Programs (CHIIPs)
2017-present K12 Training Grant Review Committee
2017-2018 KL2 Training Grant Review Committee
2018-present Scientific Co-Director, Center for Gene and Cellular Immunotherapy, Division of Oncology, Department of Medicine, Washington University School of Medicine
2018-present Medical and Scientific Director, Biological Therapy Core Facility, Siteman Cancer Center, Washington University School of Medicine
Board Certification
2006 ABIM Certified, Internal Medicine
2009 ABIM Certified, Medical Oncology
National or International Awards
1996 Howard Hughes Medical Institute (HHMI) Research Fellowship for Medical Students
1999, 2001 American Society of Hematology (ASH) Travel Award
2000 ASH Medical Student (Trainee) Award
2000 American Association of Immunologists (AAI)-Huang Foundation Trainee Achievement Award
2007 American Society of Clinical Oncology (ASCO) Young Investigator Award
2007 Future Leader in Hematology Award (Celgene)
2008 ASCO Merit Award
2008 HHMI Physician Scientist Early Career Award
2008 Edward Mallinckrodt, Jr. Foundation Award
2009 ASH Scholar Award (Basic Science, Junior Faculty)
2012 V Scholar Award, V Foundation for Cancer Research
2013 ASH Bridge Grant Program Award (declined when R01 funded)
2013 Follicular Lymphoma Pathway Award, Lymphoma Research Foundation
2014 Gabrielle's Angel Foundation Medical Award
2014 AAI Junior Faculty Travel Award
2016 Elected Member, American Society for Clinical Investigation (ASCI)
2017 Children’s Discovery Institute, Interdisciplinary Award
2017 V Scholar Translational Research Award, V Foundation for Cancer Research
2018 Siteman Cancer Center "Rock Doc" Award
2018 Siteman Cancer Center Lymphoma Team Science Award
Editorial Responsibilities
2015-present Review Editor, Frontiers in Molecular Innate Immunity
2015 Review Editor, Frontier in Immunology, NK cell biology
2015-2018 Editorial Board, Blood
2016-2018 Editorial Board, European Journal of Immunology
2018-2023 Deputy Editor, The Journal of Immunology
2018 Editor, Wintrobe’s Clinical Hematology, Edition 14 (Greer, Arber, Rodgers, Means, Appelbaum, Dispenzieri, Glader, List, Fehniger, editors). Wolters Kluwer, 2018
Professional Societies & Organizations
2004-present American Society of Hematology
      2018-2023: ASH Scientific Committee on Immunology and Host Defense
2004-present American Society for Transplantation and Cellular Therapy
2008-present Society for Natural Immunity
      2018-2021: President-Elect
      2021-2024: President
2008-present Alliance Cooperative Group
      Lymphoma Committee, Member
      Lymphoma Translational Sciences, Vice Chair
2010-present American Association of Immunologists
2010-present American Association for Cancer Research
      2013: AACR Annual Meeting Education Committee, Member
2014-present Site Co-PI, Clinical Immunotherapy Trials Network (CITN)